TY - JOUR
T1 - Role of Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes
AU - Rizvi, Tahir A.
AU - Lew, Kathy A.
AU - Murphy, Edwin C.
AU - Schmidt, Russell D.
N1 - Funding Information:
We express our thanks to Dr. Marie-Louise Hammarskjold (University of Virginia, Charlottesville, VA) and Dr. Eric Hunter (University of Alabama, Birmingham, AL) for providing p1234 containing MPMV CTE and pSHRM15, respectively. We also thank Dr. Harriet Robinson (University of Massachusetts Medical Center, Worcester, MA) for providing pCMV-HIV-1-Env and Dr. Antonito Panganiban (University of Wisconsin, Madison, WI) for providing pCMV-HIV-2-Env. pCMV-rev and pSV-A-MLV-env were obtained from the AIDS Research and Reference Reagent Program of the National Institutes of Health. We thank Drs. Jeffery Jones and Paul Wong (The University of Texas M. D. Anderson Cancer Center, UTMDACC), Dr. Farah Mustafa (The University of Texas at Austin, Austin, TX), and Dr. Antonito Panganiban for stimulating discussions and critique of the manuscript. Editorial assistance from Sunita Patterson, Scientific Publications, is greatly appreciated. RNA secondary structure analysis was performed at UTMDACC Computational Analysis Facility supported in part by a core grant from the National Cancer Institute (CA-16672). This work was supported in part by a grant from the Biomedical Research Support Committee and by institutional funds.
PY - 1996/10/15
Y1 - 1996/10/15
N2 - To study Mason-Pfizer monkey virus (MPMV) replication over a single round, virus particles were generated that contain a replication-defective vector encoding a dominant selectable marker, the hygromycin B phosphotransferase (hyg(r)) gene. Genetic complementation with a homologous MPMV envelope glycoprotein (Env-gp) or pseudotyping by several heterologous Env-gps from a variety of viruses resulted in infectious MPMV particles containing the replication-defective RNA. Recently, it has been shown that human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) Rev and Rev-responsive element (RRE) functions can be substituted in vitro by a cis-acting sequence, the constitutive transport element (CTE), from simian type D retroviruses like MPMV and simian retrovirus type 1 (SRV-1). To determine whether CTE of MPMV is necessary for MPMV nucleic acid propagation, an MPMV vector that lacked the terminally located CTE was generated. Propagation of this vector was completely abrogated in the absence of CTE, showing the importance of CTE in MPMV replication. Insertion of CTE back into the MPMV genome in the sense orientation rescued replication to wild-type levels. Slot-blot analysis of nuclear versus cytoplasmic RNA fractions revealed that most of the messages were sequestered in the nucleus of cells transfected with the CTE(-) vectors and very little was transported to the cytoplasm. To test whether HIV-1 or SIV RREs could complement CTE function, the HIV-1 or SIV RREs were inserted in the CTE(-) vectors. Trans complementation of CTE(-)RRE(+) vectors with Env- and Rev- expression plasmids rescued propagation of the CTE(-) vectors. mputer analysis predicted an RNA secondary structure in MPMV CTE analogous to the HIV-1 and SIV RREs that could form three stable stem loops, the first of which contains a site similar to the Rev-binding domain in the HIV-1 RRE. The presence of a higher-order CTE structure was analyzed by mutational analysis. We conclude that CTE is important in the replication of MPMV and affects the nucleocytoplasmic transport and/or stability of viral messages similar to the Rev/RRE regulatory system of HIV-1 and SIV.
AB - To study Mason-Pfizer monkey virus (MPMV) replication over a single round, virus particles were generated that contain a replication-defective vector encoding a dominant selectable marker, the hygromycin B phosphotransferase (hyg(r)) gene. Genetic complementation with a homologous MPMV envelope glycoprotein (Env-gp) or pseudotyping by several heterologous Env-gps from a variety of viruses resulted in infectious MPMV particles containing the replication-defective RNA. Recently, it has been shown that human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) Rev and Rev-responsive element (RRE) functions can be substituted in vitro by a cis-acting sequence, the constitutive transport element (CTE), from simian type D retroviruses like MPMV and simian retrovirus type 1 (SRV-1). To determine whether CTE of MPMV is necessary for MPMV nucleic acid propagation, an MPMV vector that lacked the terminally located CTE was generated. Propagation of this vector was completely abrogated in the absence of CTE, showing the importance of CTE in MPMV replication. Insertion of CTE back into the MPMV genome in the sense orientation rescued replication to wild-type levels. Slot-blot analysis of nuclear versus cytoplasmic RNA fractions revealed that most of the messages were sequestered in the nucleus of cells transfected with the CTE(-) vectors and very little was transported to the cytoplasm. To test whether HIV-1 or SIV RREs could complement CTE function, the HIV-1 or SIV RREs were inserted in the CTE(-) vectors. Trans complementation of CTE(-)RRE(+) vectors with Env- and Rev- expression plasmids rescued propagation of the CTE(-) vectors. mputer analysis predicted an RNA secondary structure in MPMV CTE analogous to the HIV-1 and SIV RREs that could form three stable stem loops, the first of which contains a site similar to the Rev-binding domain in the HIV-1 RRE. The presence of a higher-order CTE structure was analyzed by mutational analysis. We conclude that CTE is important in the replication of MPMV and affects the nucleocytoplasmic transport and/or stability of viral messages similar to the Rev/RRE regulatory system of HIV-1 and SIV.
UR - http://www.scopus.com/inward/record.url?scp=0030588211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030588211&partnerID=8YFLogxK
U2 - 10.1006/viro.1996.0558
DO - 10.1006/viro.1996.0558
M3 - Article
C2 - 8874512
AN - SCOPUS:0030588211
SN - 0042-6822
VL - 224
SP - 517
EP - 532
JO - Virology
JF - Virology
IS - 2
ER -